Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - OTHER LONG-TERM ASSETS
Other Long-term Assets CHRS - Coherus BioSciences, Inc.
71.3 M
LAST VALUE
43.75%
2 YEAR CAGR
33.37%
5 YEAR CAGR
119.86%
10 YEAR CAGR